EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin -prospective, randomized trial comparing a 7-day rifabutin-based triple therapy with a high-dose omeprazole/amoxicillin dual therapy



Treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin -prospective, randomized trial comparing a 7-day rifabutin-based triple therapy with a high-dose omeprazole/amoxicillin dual therapy



Gut 51(Supplement 2): A91-A92, September




(PDF 0-2 workdays service: $29.90)

Accession: 035980491

Download citation: RISBibTeXText



Related references

Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Alimentary Pharmacology & Therapeutics 24(2): 395-403, 2006

Seven day triple therapy with esomeprazole, rifabutin and amoxicillin is effective in eradicating helicobacter pylori resistant to both metronidazole and clarithromycin a prospective, randomized multicenter trial. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M1486, 2003

High-dose omeprazole/amoxicillin therapy versus quadruple therapy for treatment of Helicobacter pylori resistant against both metronidazole and clarithromycin A prospective, randomized cross-over study. Gastroenterology 120(5 Supplement 1): A 120, April, 2001

High-dose omeprazole/amoxicillin therapy versus quadruple therapy against Helicobacter pylori resistant against both metronidazole and clarithromycin A prospective, randomized, cross-over study. Gut 47(Supplement 1): A99-A100, October, 2000

A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. Canadian Journal of Gastroenterology 17(9): 533-538, 2003

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 8(4): 310-319, August, 2003

Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication. Asian Pacific Journal of Cancer Prevention 18(4): 927-932, 2017

A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of Helicobacter pylori. American Journal of Gastroenterology 93(9): 1436-1442, 1998

Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of helicobacter pylori in duodenal ulcer patients: A prospective, randomized, multicenter, North American trial. American Journal of Gastroenterology 98(3 Supplement): 562-567, March, 2003

Dual therapy using a double dose of lansoprazole with amoxicillin versus triple therapy using a double dose of lansoprazole, amoxicillin, and clarithromycin to eradicate Helicobacter pylori infection: results of a prospective randomized open study. American Journal of Gastroenterology 93(9): 1531-1534, 1998

New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese prospective, randomized, multicentre trial. Journal of Antimicrobial ChemoTherapy, 2018

Comparison of omeprazole, metronidazole and clarithromycin with omeprazole/amoxicillin dual-therapy for the cure of Helicobacter pylori infection. Digestion 59(6): 646-650, 1998

Helicobacter pylori eradication with ecabet sodium, omeprazole, amoxicillin, and clarithromycin versus bismuth, omeprazole, amoxicillin, and clarithromycin quadruple therapy: a randomized, open-label, phase IV trial. Helicobacter 17(6): 458-465, 2013

Dual therapy versus triple therapy High dose of lansoprazole plus amoxicillin in combination or not with clarithromycin for Helicobacter pylori infection. Gut 37(SUPPL 1): A92, 1995

Esomeprazole-based triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance A prospective, randomized, multicenter Trial. Alimentary Pharmacology & Therapeutics 18(8): 799-804, 15th October, 2003